IR vs OGEN · P/E 49, rev $7.24B vs rev $37.7K
Ingersoll Rand Inc (IR) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the IR and OGEN stock pages for the full models.
Not investment advice.